Bringing science and development together through news and analysis

Image credit: EC/ECHO/Cyprien Fabre

Speed read

  • Researchers worldwide have less than three weeks to apply for cash

  • The money will come from a UK humanitarian crisis fund launched in 2013

  • Proposals will be rapidly reviewed to allow work to start as soon as possible

An emergency call for research projects on Ebola that will tap into a humanitarian crisis fund is being launched today by UK-based medical research charity the Wellcome Trust and the Department for International Development.

The call aims to better inform the fight against current and future Ebola outbreaks and is open to researchers worldwide in fields including anthropology, clinical management, diagnosis, disease control and prevention, ethics, health systems, social mobilisation, surveillance and treatment.

“What we learn could also change the way we approach future outbreaks, providing us with tested tools and techniques that were not available to public health authorities this time.”

Jeremy Farrar, Wellcome Trust

The deadline is 8 September and the idea is to immediately review proposals to allow researchers to start work as soon as possible.

It is unclear how much money will be made available from the £6.5 million (around US$10.8 million) within the overall Research for Health in Humanitarian Crises (R2HC) fund.

A Wellcome Trust-DFID press release says: “The size and number of grants to be awarded will depend on the number of high-quality applications received that are within the scope of the call.”

In the release, Justine Greening, the United Kingdom’s international development secretary, added: “This will help us better equip those working on the ground so they can tackle the outbreak as effectively as possible and prevent more people contracting this terrible disease.”

Wellcome Trust director Jeremy Farrar said in the release: “We believe rapid research into humanitarian interventions and therapeutics can have an impact on treatment and containment during the present outbreak.

“What we learn could also change the way we approach future outbreaks, providing us with tested tools and techniques that were not available to public health authorities this time.”

The current Ebola outbreak in West Africa continues to spread. So far, it has killed more than 1,300 people, according to the WHO.

The WHO has declared it an international emergency — a rare move — and has ruled it to be ethical to provide experimental drugs not previously tested on humans for compassionate care of Ebola patients.

Yet, the supply of experimental treatments is limited, and some experts are calling for the supply of such drugs to be scaled up, as seen in the opinion pages of this week’s Nature.

Other coverage, including a report in UK newspaper The Independent last week (13 August), has highlighted that the outbreak’s effect on healthcare provision may lead to many more people dying from other treatable diseases, such as malaria, pneumonia and diarrhoea.

An article in Bloomberg Businessweek used the global burden of disease estimates to put the numbers of deaths in perspective: for example, 298 people died from Ebola in approximately four months in Sierra Leone compared with an estimated 650 from meningitis, 670 from tuberculosis, 790 from HIV/AIDS, 845 from diarrhoeal diseases and more than 3,000 from malaria.

Link to R2HC’s Ebola health research call
Link to article in Nature
Link to article in The Independent
Link to article in Bloomberg Businessweek
Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.